Articles tagged with "Life Sciences"
Sort by

UK’s first AI-driven Level 3 lab launches first commercial project
January 18, 2026
A joint British-Canadian initiative for infectious disease vaccines will be the first commercial project to be carried out in the new Liverpool Robotic Infection Research Laboratory.

Sounding cocci-ed
January 11, 2026
Broadcasters have a duty to promote science but when they do, it helps to get the details right, cautions Professor Brian J Ford.

Study links variants in single gene to incidences of dementia
January 11, 2026
New research from UCL has identified variations in a single gene as an under-recognised target for dementia therapies.

New towns challenge Oxbridge supercluster domination
January 9, 2026
Two of Britain’s post-war new towns are challenging Oxford and Cambridge’s domination of the country’s science and technology supercluster, claims a new report by commercial leaders.

Breast cancer is world’s most studied disease for fifth year
January 8, 2026
Phesi’s annual report on the world’s clinical trials has revealed that breast cancer has maintained its position as the most studied disease for the fifth year in succession.

Stars present and future
January 5, 2026
Another strong showing across the board in a hard-fought contest for the Lab Awards 2025.

FreshCheck funding enables expansion into healthcare applications
January 4, 2026
Imperial College London Startup FreshCheck has been awarded £150,000 to aid the rollout of its hygiene verification technology.

Big Ask: Bruntwood’s Kath Mackay
December 22, 2025
Regional innovation ecosystems are crucial to ensure university spin-outs are retained and nurtured to play their part in the UK R&D sector, says Dr Kath Mackay, chief scientific officer at...
Nutritional nuts come with a Christmas bonus
December 22, 2025
They’re a staple of the holiday season and one of the few Christmas foodstuffs to enjoy a reputation for nutritional benefits…

Lab Babble: Epochs of contamination
December 15, 2025
LLMs and nukes: not so different, says Russ Swan.

